Sequenom Inc (SQNM.OQ)
SQNM.OQ on NASDAQ Stock Exchange Global Select Market
2.96USD
1 Aug 2013
2.96USD
1 Aug 2013
Price Change (% chg)
$-0.04 (-1.33%)
$-0.04 (-1.33%)
Prev Close
$3.00
$3.00
Open
$3.02
$3.02
Day's High
$3.05
$3.05
Day's Low
$2.94
$2.94
Volume
762,573
762,573
Avg. Vol
614,650
614,650
52-wk High
$5.36
$5.36
52-wk Low
$2.65
$2.65
About
Manufactures DNA detection and sequencing equipment. The Company's two business units combine to utilize their MassARRAY system, SNP assay portfolio, disease gene discovery programs and DNA sample repository. Sequenom provides genetic analysis products that translate genomic science into solutions for biomedical research,... (more)
Overall
| Beta: | 0.58 |
| Market Cap (Mil.): | $347.24 |
| Shares Outstanding (Mil.): | 115.36 |
| Dividend: | -- |
| Yield (%): | -- |
Financials
| SQNM.OQ | Industry | Sector | |
|---|---|---|---|
| P/E (TTM): | -- | 66.39 | 37.76 |
| EPS (TTM): | -1.07 | -- | -- |
| ROI: | -95.26 | 4.99 | 18.76 |
| ROE: | -258.01 | 9.80 | 19.59 |
Sequenom shares plunge on weak results, downgrades
- Shares of Sequenom Inc fell as much as 36 percent, a day after the life sciences company reported a jump in its second-quarter loss and prompted analysts to slash their ratings and price targets on the stock.
Sequenom loss widens as billing changes delay reimbursements
- Life sciences company Sequenom Inc reported a bigger-than-expected quarterly loss as changes made by the Centers for Medicare & Medicaid Services to billing codes delayed reimbursements on its tests.
Competitors
| Price | Change | |
|---|---|---|
| Abbott Laboratories (ABT.N) | $36.84 | +0.21 |
| Life Technologies Corp. (LIFE.OQ) | $74.78 | +0.18 |
| Illumina, Inc. (ILMN.OQ) | $79.45 | -0.37 |
| Biotage AB (BIOT.ST) | 9.30kr | +0.10 |
| Fluidigm Corporation (FLDM.OQ) | $17.79 | +0.03 |
| Luminex Corporation (LMNX.OQ) | $20.00 | +0.09 |
Earnings vs.
Estimates
Analyst Research Reports
| Report Title | Price |
|---|---|
|
Provider: Thomson Reuters Stock Report
|
$25.00
|
|
Provider: ValuEngine, Inc.
|
$25.00
|
|
Provider: S&P Capital IQ Quantitative Report
|
$69.00
|
|
Provider: Pechala's Reports
|
$15.00
|
|
Provider: Zacks Investment Research Inc.
|
$12.00
|
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

